JP2020518269A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518269A5
JP2020518269A5 JP2019560667A JP2019560667A JP2020518269A5 JP 2020518269 A5 JP2020518269 A5 JP 2020518269A5 JP 2019560667 A JP2019560667 A JP 2019560667A JP 2019560667 A JP2019560667 A JP 2019560667A JP 2020518269 A5 JP2020518269 A5 JP 2020518269A5
Authority
JP
Japan
Prior art keywords
vector
ciliopathy
seq
promoter
vector according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560667A
Other languages
English (en)
Japanese (ja)
Other versions
JP7759174B2 (ja
JP2020518269A (ja
Filing date
Publication date
Priority claimed from GBGB1707212.5A external-priority patent/GB201707212D0/en
Application filed filed Critical
Publication of JP2020518269A publication Critical patent/JP2020518269A/ja
Publication of JP2020518269A5 publication Critical patent/JP2020518269A5/ja
Priority to JP2025093546A priority Critical patent/JP2025120285A/ja
Application granted granted Critical
Publication of JP7759174B2 publication Critical patent/JP7759174B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560667A 2017-05-05 2018-05-04 繊毛病のための遺伝子治療 Active JP7759174B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025093546A JP2025120285A (ja) 2017-05-05 2025-06-04 繊毛病のための遺伝子治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1707212.5A GB201707212D0 (en) 2017-05-05 2017-05-05 Gene therapy for ciliopathies
GB1707212.5 2017-05-05
PCT/GB2018/051219 WO2018203092A1 (en) 2017-05-05 2018-05-04 Gene therapy for ciliopathies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025093546A Division JP2025120285A (ja) 2017-05-05 2025-06-04 繊毛病のための遺伝子治療

Publications (3)

Publication Number Publication Date
JP2020518269A JP2020518269A (ja) 2020-06-25
JP2020518269A5 true JP2020518269A5 (cg-RX-API-DMAC7.html) 2021-07-26
JP7759174B2 JP7759174B2 (ja) 2025-10-23

Family

ID=59065740

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560667A Active JP7759174B2 (ja) 2017-05-05 2018-05-04 繊毛病のための遺伝子治療
JP2025093546A Pending JP2025120285A (ja) 2017-05-05 2025-06-04 繊毛病のための遺伝子治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025093546A Pending JP2025120285A (ja) 2017-05-05 2025-06-04 繊毛病のための遺伝子治療

Country Status (8)

Country Link
US (2) US12171794B2 (cg-RX-API-DMAC7.html)
EP (1) EP3628011B1 (cg-RX-API-DMAC7.html)
JP (2) JP7759174B2 (cg-RX-API-DMAC7.html)
CN (1) CN110753559A (cg-RX-API-DMAC7.html)
AU (1) AU2018262427B2 (cg-RX-API-DMAC7.html)
CA (1) CA3060187A1 (cg-RX-API-DMAC7.html)
GB (1) GB201707212D0 (cg-RX-API-DMAC7.html)
WO (1) WO2018203092A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201707212D0 (en) 2017-05-05 2017-06-21 Ucl Business Plc Gene therapy for ciliopathies
ES2974368T3 (es) * 2019-02-14 2024-06-27 Ethris Gmbh Análisis del efecto de un polirribonucleótido sobre la ciliogénesis
CN114787180A (zh) * 2019-10-17 2022-07-22 斯特里迪比奥公司 用于治疗c型尼曼-匹克病的腺相关病毒载体
GB202005641D0 (en) * 2020-04-17 2020-06-03 Ucl Business Plc Gene therapy for bardet-biedl syndrome
CN116042719B (zh) * 2022-12-28 2025-11-11 蓝图生物医药(广州)有限公司 一种重组腺相关病毒载体及其应用
WO2025049923A2 (en) * 2023-08-31 2025-03-06 The Board Of Trustees Of The Leland Stanford Junior University Novel treatments of ciliopathies
WO2026087074A1 (en) * 2024-10-21 2026-04-30 Invision 20/20 Bardet-biedl syndrome 10 (bbs10) protein gene therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962788B2 (en) * 2002-05-30 2005-11-08 University Of Iowa Research Foundation Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof
US8163482B2 (en) * 2006-02-23 2012-04-24 Nicholas Katsanis BBS10 related diagnostic methods for Bardet-Biedl syndrome
EP2394667A1 (en) 2010-06-10 2011-12-14 Laboratorios Del Dr. Esteve, S.A. Vectors and sequences for the treatment of diseases
CN105209619B (zh) * 2013-03-11 2018-10-12 泰莱托恩基金会 miR-204和miR-211及其用途
GB201707212D0 (en) 2017-05-05 2017-06-21 Ucl Business Plc Gene therapy for ciliopathies

Similar Documents

Publication Publication Date Title
JP2025120285A5 (cg-RX-API-DMAC7.html)
AU2026202070A1 (en) Modified AAV capsid polypeptides for treatment of muscular diseases
JP2023537625A5 (cg-RX-API-DMAC7.html)
JP2023534999A5 (cg-RX-API-DMAC7.html)
JP2021531752A5 (cg-RX-API-DMAC7.html)
JP2019505588A5 (ja) 遺伝子治療ベクターおよび医薬組成物
JP2021512649A5 (cg-RX-API-DMAC7.html)
JP2020203894A5 (cg-RX-API-DMAC7.html)
JP2021520203A5 (cg-RX-API-DMAC7.html)
JP2022529782A5 (cg-RX-API-DMAC7.html)
JP2020528734A5 (cg-RX-API-DMAC7.html)
JP7671483B2 (ja) 癌の治療
JP2018508519A5 (cg-RX-API-DMAC7.html)
CA3004742A1 (en) Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2023535956A5 (cg-RX-API-DMAC7.html)
JP2018510620A5 (cg-RX-API-DMAC7.html)
US20250297285A1 (en) Transgene cassettes designed to express a human mecp2 gene
Cappa et al. Gene therapy for rare central nervous system diseases comes to age
JP2022539238A5 (cg-RX-API-DMAC7.html)
JP2019537446A5 (cg-RX-API-DMAC7.html)
JP2021510301A5 (cg-RX-API-DMAC7.html)
JP2020527335A5 (cg-RX-API-DMAC7.html)
JP2018509154A5 (cg-RX-API-DMAC7.html)
CA3115637A1 (en) Vectors containing aimp2-dx2 and target nucleic acids for mir-142 and uses thereof